← Leaderboards
Stefano Tiziani
University Of Texas At Austin
$2,053,872
Attributed
$4,916,766
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $983.5K · FY2016–23$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,916,766 · 2
By mechanism
R01$4,916,766 · 2
Top collaborators
- John Digiovanni5 shared
- Marina Y Konopleva5 shared
- Amit Verma5 shared
Most similar at University Of Texas At Austin
Same institution · by research overlap
- John Digiovanni$26,040,423
- Guangbin Dong$6,978,172
- Gabrelle Lavender Hackman$117,901
Others in their field
Top investigators on “Neoplastic Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$139,710,838
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Bruce W Stillman · Cold Spring Harbor Laboratory$25,455,900
- Ralph Parchment · Leidos Biomedical Research, Inc.$25,266,647
- Andrea Califano · Columbia University Health Sciences$22,374,316
- Wendell A Lim · University Of California, San Francisco$22,334,734
Research focus
Neoplastic CellIn VitroMalignant NeoplasmsMouse ModelCell GrowthCell SurvivalGrowthIn VivoMetabolic PathwayMitochondriaMetabolomicsTumorMetabolismMetabolicCellsGlutamineBaseCxcr4 GeneAmerican Cancer SocietyDiagnosisAllograftingCancer EtiologyCurcuminDiet
Grant awards (10)
Identification of Natural Compound Combinations for Prevention of Prostate Cancer$491,916
R01 · FY2023 · CA
Identification of Natural Compound Combinations for Prevention of Prostate Cancer$491,916
R01 · FY2022 · CA
Identification of Natural Compound Combinations for Prevention of Prostate Cancer$501,955
R01 · FY2021 · CA
Identification of Natural Compound Combinations for Prevention of Prostate Cancer$501,955
R01 · FY2020 · CA
Therapeutic targeting of glutamine metabolism in MDS$481,538
R01 · FY2020 · CA
Identification of Natural Compound Combinations for Prevention of Prostate Cancer$501,955
R01 · FY2019 · CA
Therapeutic targeting of glutamine metabolism in MDS$467,092
R01 · FY2019 · CA
Therapeutic targeting of glutamine metabolism in MDS$496,810
R01 · FY2018 · CA
Therapeutic targeting of glutamine metabolism in MDS$474,750
R01 · FY2017 · CA
Therapeutic targeting of glutamine metabolism in MDS$506,879
R01 · FY2016 · CA